168 related articles for article (PubMed ID: 33960957)
1. Characteristics of benign adrenocortical adenomas with 18F-FDG PET accumulation.
Ishiwata K; Suzuki S; Igarashi K; Ruike Y; Naito K; Ishida A; Deguchi-Horiuchi H; Fujimoto M; Koide H; Imamura Y; Sakamoto S; Ichikawa T; Ikeda JI; Yokote K
Eur J Endocrinol; 2021 Jun; 185(1):155-165. PubMed ID: 33960957
[TBL] [Abstract][Full Text] [Related]
2. Uptake of 18F-FDG in Adrenal Adenomas Is Associated With Unenhanced CT Value and Constituent Cells.
Murayama R; Nishie A; Hida T; Baba S; Inokuchi J; Oda Y; Honda H
Clin Nucl Med; 2019 Dec; 44(12):943-948. PubMed ID: 31490313
[TBL] [Abstract][Full Text] [Related]
3. The computed tomography adrenal wash-out analysis properly classifies cortisol secreting adrenocortical adenomas.
Humbert AL; Lecoanet G; Moog S; Bouderraoui F; Bresler L; Vignaud JM; Chevalier E; Brunaud L; Klein M; Cuny T
Endocrine; 2018 Mar; 59(3):529-537. PubMed ID: 29332161
[TBL] [Abstract][Full Text] [Related]
4. High [18F] 2-fluoro-2-deoxy-D-glucose (FDG) uptake of adrenocortical adenoma showing subclinical Cushing's syndrome.
Shimizu A; Oriuchi N; Tsushima Y; Higuchi T; Aoki J; Endo K
Ann Nucl Med; 2003 Jul; 17(5):403-6. PubMed ID: 12971640
[TBL] [Abstract][Full Text] [Related]
5. 18F-FDG PET for the identification of adrenocortical carcinomas among indeterminate adrenal tumors at computed tomography scanning.
Nunes ML; Rault A; Teynie J; Valli N; Guyot M; Gaye D; Belleannee G; Tabarin A
World J Surg; 2010 Jul; 34(7):1506-10. PubMed ID: 20396886
[TBL] [Abstract][Full Text] [Related]
6. F-18 fluorodeoxyglucose positron emission tomography-positive benign adrenal cortical adenoma: imaging features and pathologic correlation.
Rao SK; Caride VJ; Ponn R; Giakovis E; Lee SH
Clin Nucl Med; 2004 May; 29(5):300-2. PubMed ID: 15069328
[TBL] [Abstract][Full Text] [Related]
7. Adrenal-to-liver SUV ratio is the best parameter for differentiation of adrenal metastases from adenomas using 18F-FDG PET/CT.
Watanabe H; Kanematsu M; Goshima S; Kondo H; Kawada H; Noda Y; Moriyama N
Ann Nucl Med; 2013 Aug; 27(7):648-53. PubMed ID: 23625579
[TBL] [Abstract][Full Text] [Related]
8. 18F-FDG PET/CT image findings of a dog with adrenocortical carcinoma.
Lee D; Yun T; Koo Y; Chae Y; Chang D; Yang MP; Kang BT; Kim H
BMC Vet Res; 2022 Jan; 18(1):15. PubMed ID: 34980137
[TBL] [Abstract][Full Text] [Related]
9. Characterization of adrenocortical tumors by
Paladino NC; Guérin C; Lowery A; Attard A; Essamet W; Slotema E; Morange I; Castinetti F; Brue T; Loundou A; Taïeb D; Sebag F
Surg Oncol; 2018 Jun; 27(2):231-235. PubMed ID: 29937176
[TBL] [Abstract][Full Text] [Related]
10. Adrenal findings in FDG-PET: analysis of a cohort of 1021 patients from a cancer center.
Maciel J; Cavaco D; Fraga D; Donato S; Simões H; Sousa R; Simões-Pereira J
Hormones (Athens); 2023 Mar; 22(1):131-138. PubMed ID: 36477790
[TBL] [Abstract][Full Text] [Related]
11. Benign hormone-secreting adenoma within a larger adrenocortical mass showing intensely increased activity on
Papadakis GZ; Millo C; Stratakis CA
Endocrine; 2016 Oct; 54(1):269-270. PubMed ID: 27154873
[TBL] [Abstract][Full Text] [Related]
12. Adrenocortical oncocytoma displaying intense activity on 18F-FDG-PET: a case report and a literature review.
Kim DJ; Chung JJ; Ryu YH; Hong SW; Yu JS; Kim JH
Ann Nucl Med; 2008 Nov; 22(9):821-4. PubMed ID: 19039562
[TBL] [Abstract][Full Text] [Related]
13. Preoperative characterization of indeterminate large adrenal masses with dual tracer PET-CT using fluorine-18 fluorodeoxyglucose and gallium-68-DOTANOC: initial results.
Naswa N; Sharma P; Soundararajan R; Patnecha M; Lata S; Kumar R; Malhotra A; Bal C
Diagn Interv Radiol; 2013; 19(4):294-8. PubMed ID: 23439252
[TBL] [Abstract][Full Text] [Related]
14. Characterization of lipid-rich adrenal tumors by FDG PET/CT: Are they hormone-secreting or not?
Takanami K; Kaneta T; Morimoto R; Satoh F; Nakamura Y; Takase K; Takahashi S
Ann Nucl Med; 2014 Feb; 28(2):145-53. PubMed ID: 24272068
[TBL] [Abstract][Full Text] [Related]
15. RNA Sequencing and Somatic Mutation Status of Adrenocortical Tumors: Novel Pathogenetic Insights.
Di Dalmazi G; Altieri B; Scholz C; Sbiera S; Luconi M; Waldman J; Kastelan D; Ceccato F; Chiodini I; Arnaldi G; Riester A; Osswald A; Beuschlein F; Sauer S; Fassnacht M; Appenzeller S; Ronchi CL
J Clin Endocrinol Metab; 2020 Dec; 105(12):. PubMed ID: 32875319
[TBL] [Abstract][Full Text] [Related]
16. FDG PET/CT Scan and Functional Adrenal Tumors: A Pilot Study for Lateralization.
Patel D; Gara SK; Ellis RJ; Boufraqech M; Nilubol N; Millo C; Stratakis CA; Kebebew E
World J Surg; 2016 Mar; 40(3):683-9. PubMed ID: 26324161
[TBL] [Abstract][Full Text] [Related]
17. 18F-fluorodeoxyglucose positron emission tomography as a diagnostic tool for malignancy of adrenocortical tumours? Preliminary results in 13 consecutive patients.
Tenenbaum F; Groussin L; Foehrenbach H; Tissier F; Gouya H; Bertherat J; Dousset B; Legmann P; Richard B; Bertagna X
Eur J Endocrinol; 2004 Jun; 150(6):789-92. PubMed ID: 15191348
[TBL] [Abstract][Full Text] [Related]
18. Relationship between clear cell/compact cell ratio and computed tomographic attenuation number in adrenocortical adenoma.
Ichiyanagi O; Sasagawa I; Izumi T; Ohji H; Suzuki H; Nakada T; Sugai Y; Yamaguchi K
Int Urol Nephrol; 1999; 31(5):585-90. PubMed ID: 10755348
[TBL] [Abstract][Full Text] [Related]
19. Whole Body Metabolic Tumor Volume and Total Lesion Glycolysis Predict Survival in Patients with Adrenocortical Carcinoma.
Satoh K; Patel D; Dieckmann W; Nilubol N; Kebebew E
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S714-20. PubMed ID: 26282908
[TBL] [Abstract][Full Text] [Related]
20. Cortisol-Producing Adrenal Adenomas With Intense Activity on 68Ga-Pentixafor PET/CT.
Ding J; Tong A; Zhang Y; Zhang H; Huo L
Clin Nucl Med; 2021 Apr; 46(4):350-352. PubMed ID: 33492858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
